Among these findings, the NF-κB pathway, discovered earlier and studied extensively, has been reported to be closely related to GEM chemoresistance and is expected to be a potential therapeutic target for pancreatic cancer [40]. This evidence concerns the gene NFKB1 and pancreatic neoplasm.